Hirohito Seki, Akiko Ogiya, Naomi Nagura, Ayaka Shimo, Kazutaka Narui, Shinsuke Sasada, Makoto Ishitobi, Hiroko Nogi, Naoto Kondo, Teruhisa Sakurai, et al. Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi-institutional study. Breast cancer (Tokyo, Japan). 2024. 31. 5. 935-944
Emi Onuma, Shin Saito, Taku Tsuburai, Hiromi Yoshikata, Shoko Adachi, Shinya Yamamoto, Kazutaka Narui, Tomonari Hayama, Mariko Murase, Taichi Mizushima, et al. Effect of bisphosphonate and denosumab treatment on TBS in Japanese breast cancer patients with AIBL. Journal of bone and mineral metabolism. 2024
Hideyuki Yamada, Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Hiroshi Fujimoto, Junta Sakakibara, Yoshie Hasegawa, Shintaro Takao, Akimitsu Yamada, et al. Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells. Scientific reports. 2024. 14. 1. 14146-14146
Shinsuke Sasada, Naomi Nagura, Ayaka Shimo, Akiko Ogiya, Miho Saiga, Hirohito Seki, Hiroki Mori, Naoto Kondo, Makoto Ishitobi, Kazutaka Narui, et al. Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024. 50. 6. 108360-108360
Hiroko Nogi, Akiko Ogiya, Makoto Ishitobi, Chikako Yamauchi, Hiroki Mori, Ayaka Shimo, Kazutaka Narui, Naomi Nagura, Hirohito Seki, Shinsuke Sasada, et al. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy. Breast cancer (Tokyo, Japan). 2024. 31. 3. 507-518
Takafumi Sangai, Yuichiro Kikawa, Mitsuchika Hosoda, Yohei Hamanaka, Yuko Tanabe, Tatsuya Yoshida, Kaori Tane, Daisuke Takabatake, Tetsuhiko Taira, Kazuhiro Araki, et al. Randomized study comparing electronic patient reported outcomes (ePROs) monitoring with routine follow up during trastuzumab deruxtecan treatment in patients with inoperable or metastatic breast cancer (PRO-DUCE study). CANCER RESEARCH. 2022. 82. 4
Akimitsu Yamada, Naoki Hayashi, Hiraku Kumamaru, Masayuki Nagahashi, Shiori Usune, Hiroaki Miyata, Takashi Ishikawa, Kazutaka Narui, Itaru Endo, Shigeru Imoto, et al. Prognostic impact of postmastectomy radiation therapy in breast cancer patients with T1, 2 and 1-3 lymph nodes from Japan Breast Cancer Registry. CANCER RESEARCH. 2022. 82. 4
